Papillary thyroid cancer—Aggressive variants and impact on management: A narrative review

A Coca-Pelaz, JP Shah, JC Hernandez-Prera… - Advances in …, 2020 - Springer
Introduction Aggressive variants of papillary thyroid cancer (PTC) have been described with
increasing frequency. These variants include diffuse sclerosing variant, tall cell variant …

Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance

G Acquaviva, M Visani, A Repaci, KJ Rhoden… - …, 2018 - Wiley Online Library
Thyroid cancer is the most common endocrine malignancy. Knowledge of the molecular
pathology of thyroid tumours originating from follicular cells has greatly advanced in the past …

Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells

C Koelsche, A Wöhrer, A Jeibmann, J Schittenhelm… - Acta …, 2013 - Springer
Ganglioglioma is a rare CNS tumor with a benign biological behavior. Recently, the BRAF
V600E mutation was identified in approximately 20% of gangliogliomas. Here, we analyzed …

BRAF V600E mutation-specific antibody: a review

LL Ritterhouse, JA Barletta - Seminars in diagnostic pathology, 2015 - Elsevier
The significance of BRAF mutations in neoplasia was first recognized in 2002 when
mutations were discovered in a broad range of cancers. Numerous subsequent studies …

Clinicopathological relevance of BRAF mutations in human cancer

S Pakneshan, A Salajegheh, RA Smith… - Pathology-Journal of …, 2013 - journals.lww.com
BRAF represents one of the most frequently mutated protein kinase genes in human
tumours. The mutation is commonly tested in pathology practice. BRAF mutation is seen in …

Application of immunohistochemistry in thyroid pathology

H Liu, F Lin - Archives of Pathology and Laboratory …, 2015 - meridian.allenpress.com
Context Accurate classification of follicular-patterned thyroid lesions is not always an easy
task on routine surgical hematoxylin-eosin–stained or cytologic fine-needle aspiration …

[HTML][HTML] Detection of BRAF p. V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing

E Colomba, Z Hélias-Rodzewicz… - The Journal of molecular …, 2013 - Elsevier
BRAF p. V600 mutation detection recently became necessary to treat metastatic melanoma
patients with vemurafenib. This study compares different methods of detection of BRAF …

BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome

CW Toon, MD Walsh, A Chou, D Capper… - The American journal …, 2013 - journals.lww.com
BRAFV600E mutation in microsatellite-unstable (MSI) colorectal carcinomas (CRCs)
virtually excludes Lynch syndrome (LS). In microsatellite-stable (MSS) CRCs it predicts poor …

Diffuse sclerosing variant of papillary thyroid carcinoma—an update of its clinicopathological features and molecular biology

S Pillai, V Gopalan, RA Smith, AKY Lam - Critical reviews in oncology …, 2015 - Elsevier
Diffuse sclerosing variant of papillary thyroid carcinoma (DSVPTC) is an uncommon variant
of papillary thyroid carcinoma. The aim of this review is to critically analyse the features of …

BRAF V600E‐specific immunohistochemistry for the exclusion of Lynch syndrome in MSI‐H colorectal cancer

D Capper, A Voigt, G Bozukova… - … journal of cancer, 2013 - Wiley Online Library
The differentiation between hereditary and sporadic microsatellite‐unstable (MSI‐H)
colorectal cancer is a crucial step in Lynch syndrome diagnostics. Within MSI‐H colorectal …